Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2003
08/28/2003WO2003070951A1 Arteriosclerosis-specific gene and utilization thereof
08/28/2003WO2003070938A1 Gene expression data analyzer, and method, program and recording medium for gene expression data analysis
08/28/2003WO2003070937A1 Protein having osteogenic protein-binding region and gene encoding the same
08/28/2003WO2003070936A1 Novel polypeptide
08/28/2003WO2003070926A1 New nucleotide sequences encoding human phb: polyprenyltransferase polypeptides
08/28/2003WO2003070907A2 Novel fungal lipase
08/28/2003WO2003070899A2 Phospho-specific antibodies to flt3 and uses thereof
08/28/2003WO2003070894A2 A non-invasive diagnostic test utilizing histone modification markers
08/28/2003WO2003070891A2 Method of determining adenovirus particle concentration
08/28/2003WO2003070883A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
08/28/2003WO2003070879A2 Cyclin dependent kinase 5 phosphorylation of disabled 1 protein
08/28/2003WO2003070876A2 Method for attaching nucleic acid molecules to electrically conductive surfaces
08/28/2003WO2003070842A1 Composition and method for measuring oil and grease repellency of paper and paperboard
08/28/2003WO2003070771A1 Rrp sequences and knockout mice and uses thereof
08/28/2003WO2003070760A2 Anti-amyloid beta antibodies and their use
08/28/2003WO2003070759A2 Method of modulating e-cadherin mediated cell adhesion
08/28/2003WO2003070752A2 Mhc-peptide complex binding ligands
08/28/2003WO2003070747A2 Insulin and igf-1 receptor agonists and antagonists
08/28/2003WO2003070738A2 Topiramate salts and compositions comprising and methods of making and using the same
08/28/2003WO2003070349A1 Apparatus with voraxial separator and analyzer
08/28/2003WO2003070321A1 Double gate transistor arrangement for receiving electrical signals from living cells
08/28/2003WO2003070316A2 Arrangement for receiving electrical signals from living cells and for stimulation
08/28/2003WO2003070265A2 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis
08/28/2003WO2003070195A2 Biglycan and related therapeutics and methods of use
08/28/2003WO2003070162A2 Par-3 compounds for therapy and diagnosis and methods for using same
08/28/2003WO2003070157A2 Vitamin d upregulated protein 1 (vdup-1) methods and uses thereof
08/28/2003WO2003070138A2 Wetness indicator having improved colorant retention
08/28/2003WO2003070131A1 A urine sample collection device
08/28/2003WO2003069999A1 Proteins for helicobacter diagnosis
08/28/2003WO2003062273A3 Modulator of the notch signalling pathway and use thereof in medical treatment
08/28/2003WO2003055911A3 Cystine-knot fold protein
08/28/2003WO2003053715A3 Anti-fraud apparatus and method for protecting valuables
08/28/2003WO2003048314A3 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips
08/28/2003WO2003044213A3 Cell and tissue arrays and microarrays and methods of use
08/28/2003WO2003043986A8 Polypeptides of moraxella (branhamella) catarrhalis
08/28/2003WO2003043524A3 Compositions and methods for accurate early pregnancy diagnosis
08/28/2003WO2003041733A9 Prion-detection business methods
08/28/2003WO2003034037A3 Apparatus and method for destacking articles
08/28/2003WO2003025018A3 Dimeric and multimeric antigen binding structure
08/28/2003WO2003018631A3 Nogo receptor homologues and their use
08/28/2003WO2003016867A3 Method and quantification assay for determining c-kit/scf/pakt status
08/28/2003WO2003016522A3 Methods and compounds for the targeting of protein to exosomes
08/28/2003WO2003015693A3 Screening and therapeutic methods for promoting wakefulness and sleep
08/28/2003WO2003014321A3 Compositions and methods for modulation of darpp-32 phosphorylation
08/28/2003WO2003014153A3 Cellular virus receptors and methods of use.
08/28/2003WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace
08/28/2003WO2003010330A3 Test system and method suitable for selecting test materials and formulations
08/28/2003WO2003008935A3 Sampling and toxicity monitoring device and method
08/28/2003WO2003008530A3 A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the method
08/28/2003WO2003004007A3 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd)
08/28/2003WO2003002105A3 Use of tyrosine kinase inhibitors for treating bone loss
08/28/2003WO2003001213A3 Total protein detection methods and devices at low ph
08/28/2003WO2002103047A3 Genomic mapping method
08/28/2003WO2002102990A3 Fibroblast growth factor and nucleic acid encoding same
08/28/2003WO2002101043A3 Regulation of human ta4 receptor
08/28/2003WO2002100349A3 Use of the parathroid hormone-2 (pth2) receptor to screen for agents to treat pain
08/28/2003WO2002100248A3 Compositions and methods relating to glucose metabolism, weight control, and food intake
08/28/2003WO2002099383A3 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
08/28/2003WO2002097051A3 Protein arrays and methods and systems for producing the same
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002096468A3 Method for the diagnosis and therapy of renal cell carcinoma
08/28/2003WO2002095413A3 Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
08/28/2003WO2002095401A3 Screening test and procedure using skin patches
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002092787A3 Human secreted proteins
08/28/2003WO2002092732A3 Lubricant composition and analysis method for same
08/28/2003WO2002088382A3 Method for analysing nucleic acid chains
08/28/2003WO2002086093A9 Methods of using a hyaluronan receptor
08/28/2003WO2002084283A3 Method for determining analyte molecules in a sample
08/28/2003WO2002083720A3 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
08/28/2003WO2002079785A3 Phosphoprotein target for insulin and its antagonists
08/28/2003WO2002075273A3 Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor
08/28/2003WO2002074797A3 Protein having multiple antigen/epitope sequences and being immobilized for the diagnosis of hiv infections
08/28/2003WO2002074048A8 P-glycoproteins and uses thereof
08/28/2003WO2002072823A3 Human g protein-coupled receptor
08/28/2003WO2002071037A3 Apparatus and method for processing and testing a biological specimen
08/28/2003WO2002070006A3 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
08/28/2003WO2002068687A3 Function and application of tob gene in central nervous system of mammal
08/28/2003WO2002063415A3 System and method for the management of genomic data
08/28/2003WO2002057774A3 Detection of trace levels of water
08/28/2003WO2002056030A3 Method and device for collecting and stabilizing a biological sample
08/28/2003WO2002054073A3 Latent human tuberculosis model, diagnostic antigens, and methods of use
08/28/2003WO2002053773A3 Method for determining skin stress or skin ageing in vitro
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
08/28/2003WO2002046467A3 Gene expression profiling of primary breast carcinomas using arrays of candidate genes
08/28/2003WO2002044736A3 Diagnosis and treatment of epidermal or skin diseases
08/28/2003WO2002044327A9 Method and apparatus for protein manipulation
08/28/2003WO2002042780A3 Apparatus and methods for separating agglutinants and disperse particles
08/28/2003WO2002036820A3 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat
08/28/2003WO2002036627A3 Interferons, uses and compositions related thereto
08/28/2003WO2002036149A3 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
08/28/2003WO2002034940A3 Methods for screening compounds that modulate lipid metabolism
08/28/2003WO2002034922A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
08/28/2003WO2002033126A3 Solid support assay systems and methods utilizing non-standard bases
08/28/2003WO2002027022A3 Methods for diagnosing and treating autosomal dominant optic atrophy
08/28/2003WO2002012470A3 A member of the lysyl oxidase gene family
08/28/2003WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
08/28/2003WO2002010763A3 Marker for antidepressant therapy and methods related thereto
08/28/2003WO2002008767A3 Methods and kits for sequencing polypeptides
08/28/2003WO2002008399A3 Human kinases
1 ... 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 ... 3937